Mothercare sales decline on weak UK performance
Baby and maternity retailer Mothercare reported on Thursday a decline in sales following poor performance at UK stores.
Baby and maternity retailer Mothercare reported on Thursday a decline in sales following poor performance at UK stores.
The group posted a 7.4% drop in total group sales for the 13 weeks ended on January 12th.
UK stores were the biggest contributor to the fall with a 12.9% decrease, as recent improvements to its British arm failed to pull in Christmas sales and the company closed 11 shops.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Mothercare has been scaling back stores in the UK as part of a restructuring plan to cut losses. It now has 269 stores, compared with 311 last April.
International sales, on the other hand, rose 14.8% over the same period following growth in overseas markets.
Chief Executive Simon Calver, said: "We have made solid progress during the third quarter, despite a challenging consumer backdrop for the UK and Eurozone.
"International continues to see double-digit growth and in the UK we have made further progress closing loss making stores."
He said the its retail website passed the test of peak trading at double the rate in December.
"Our work towards delivering improved value, choice and service for our customers continues to make an impact and I am very encouraged by the new ranges and innovative product ready to go into stores for spring/summer 2013."
Shares fell 2.88% to 295.50p at 11:15 Thursday.
RD
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
-
GSK share price surges after $2.2bn Zantac drug settlement
GSK has settled lawsuits in the US that alleged the drugmaker’s now-discontinued heartburn drug Zantac triggered cancer
By Chris Newlands Published
-
Will the Autumn Budget impact investment markets?
Keir Starmer has warned the Autumn Budget will be “painful”. Will it impact investment markets and should you tweak your portfolio before 30 October?
By Katie Williams Published